These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 29717530)
1. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic. Dow E; Buchanan DD; Winship IM Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry. Walsh MD; Buchanan DD; Pearson SA; Clendenning M; Jenkins MA; Win AK; Walters RJ; Spring KJ; Nagler B; Pavluk E; Arnold ST; Goldblatt J; George J; Suthers GK; Phillips K; Hopper JL; Jass JR; Baron JA; Ahnen DJ; Thibodeau SN; Lindor N; Parry S; Walker NI; Rosty C; Young JP Mod Pathol; 2012 May; 25(5):722-30. PubMed ID: 22322191 [TBL] [Abstract][Full Text] [Related]
3. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175 [TBL] [Abstract][Full Text] [Related]
4. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
5. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892 [TBL] [Abstract][Full Text] [Related]
6. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
7. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions. Kravochuck SE; Church JM ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828 [TBL] [Abstract][Full Text] [Related]
9. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
11. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience. Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051 [TBL] [Abstract][Full Text] [Related]
12. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
13. Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients. Zumstein V; Vinzens F; Zettl A; Heinimann K; Koeberle D; von Flüe M; Bolli M Swiss Med Wkly; 2016; 146():w14315. PubMed ID: 27152634 [TBL] [Abstract][Full Text] [Related]
14. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]
15. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754 [TBL] [Abstract][Full Text] [Related]
17. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733 [TBL] [Abstract][Full Text] [Related]
18. Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort. Loh Z; Williams DS; Salmon L; Dow E; John T Intern Med J; 2019 Oct; 49(10):1278-1284. PubMed ID: 30667141 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. Green RC; Parfrey PS; Woods MO; Younghusband HB J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167 [TBL] [Abstract][Full Text] [Related]
20. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]